Skip to main content

Table 4 MDR analysis for TNF SNPs and risk of gastric cancer associated with selected combination in MDR stratified by smoking status in a nested case-control study within the KMCC 19,688 enrolled cohort members.

From: The role of TNFgenetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study

  

Test accuracy

CVCa

p value b

Case

Control

OR (95% CI)c

Total

α-857

0.554

9/10

0.0799

49 (58)

227 (70)

1.0 (reference)

     

35 (42)

98 (30)

1.7 (1.0–2.8)*

 

α-857, α-308

0.577

6/10

0.0225

42 (51)

207 (65)

1.0 (reference)

     

41 (49)

110 (35)

1.8 (1.1–3.0)*

 

α-863, α-857, α-308

0.591

6/10

0.0044

42 (51)

215 (70)

1.0 (reference)

     

40 (49)

94 (30)

2.2 (1.3–3.7)**

 

α-1031, α-863, α-857, α-308 d

0.602

9/10

0.0015

36 (44)

193 (63)

1.0 (reference)

     

46 (56)

113 (37)

2.2 (1.3–3.6)**

Non-smokers

α-857

0.603

9/10

0.0636

49 (58)

227 (70)

1.0 (reference)

     

35 (42)

98 (30)

1.7 (1.0–2.7)*

 

α-857, α-308

0.664

6/10

0.0038

42 (51)

207 (65)

1.0 (reference)

     

41 (49)

110 (35)

1.8 (1.1–3.0)*

 

β 252, α-857, α-308

0.680

6/10

0.0030

34 (43)

158 (52)

1.0 (reference)

     

45 (57)

143 (48)

1.5 (0.9–2.4)

 

β 252, α-1031, α-857, α-308

0.697

8/10

0.0009

40 (51)

165 (56)

1.0 (reference)

     

39 (49)

130 (44)

1.2 (0.7–2.0)

Smokers

α-857

0.554

6/10

0.1863

51 (61)

233 (72)

1.0 (reference)

     

33 (39)

92 (28)

1.6 (1.0–2.7)*

 

α-1031, α-857

0.570

7/10

0.0130

32 (39)

151 (48)

1.0 (reference)

     

51 (61)

165 (52)

1.4 (0.9–2.4)

 

α-1031, α-863, α-857 d

0.615

10/10

0.0023

42 (51)

210 (68)

1.0 (reference)

     

40 (49)

101 (32)

2.0 (1.2–3.3)**

 

α-1031, α-863, α-857, α-308

0.662

7/10

0.0015

43 (52)

215 (70)

1.0 (reference)

     

39 (48)

91 (30)

2.1 (1.3-3.5)**

  1. * p < 0.05, ** p < 0.01
  2. a. Cross-validation consistency
  3. b. P-values were estimated by sign test.
  4. c. Among total subjects, the ORs (95% CIs) were adjusted for age, sex, smoking status (Never vs. Ever), H. Pylori infection, and CagA seropositivity, and after stratification for smoking status, the ORs (95% CIs) were adjusted for age, sex, H. Pylori infection, and CagA seropositivity, except smoking status.
  5. d. Overall best model attributed by the MDR method